Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features

Our results suggest that TLS are a frequent feature in early TNBC and that their presence, particularly at the tumor periphery, recapitulates the tumor immune microenvironment. In our series, their prognostic value outperformed that of TILs. Therefore, their easy quantification on routine HES sections and their integration into the factors classically analyzed by pathologists could improve the clinical management of TNBC, a breast cancer type whose prognosis remains too poor.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-12-11
DOI
https://doi.org/10.3389/fimmu.2024.1507371
Citations
13
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
3.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features

Evelyne Lopez‐Crapez, Pascal Roger, Florence Boissière‐Michot, Virginie Lafont et al.
13 citations
Frontiers in Immunology
Breast Cancer Treatment Studies
3.71
article

Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features

Evelyne Lopez‐Crapez, Pascal Roger, Florence Boissière‐Michot, Virginie Lafont, Séverine Guiu, Marie‐Christine Chateau, William Jacot, Priyanka Sharma, Angélique Bobrie, Simon Thézenas
article en
13 citations

Abstract

Our results suggest that TLS are a frequent feature in early TNBC and that their presence, particularly at the tumor periphery, recapitulates the tumor immune microenvironment. In our series, their prognostic value outperformed that of TILs. Therefore, their easy quantification on routine HES sections and their integration into the factors classically analyzed by pathologists could improve the clinical management of TNBC, a breast cancer type whose prognosis remains too poor.

Frontiers in ImmunologyVol. 15
Inserm (FR), Université de Montpellier (FR), Zimmer Biomet (France) (FR), Institut de Recherche en Cancérologie de Montpellier (FR), Université de Nîmes (FR)
Agence Nationale de la Recherche
Good health and well-being
Openalex Percentile: Top 6%
Breast Cancer Treatment Studies
3.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.